ECSP972101A - DERIVATIVES OF BENZOFURILE AND ITS USE - Google Patents
DERIVATIVES OF BENZOFURILE AND ITS USEInfo
- Publication number
- ECSP972101A ECSP972101A ECSP972101A ECSP972101A EC SP972101 A ECSP972101 A EC SP972101A EC SP972101 A ECSP972101 A EC SP972101A EC SP972101 A ECSP972101 A EC SP972101A
- Authority
- EC
- Ecuador
- Prior art keywords
- lower alkyl
- disorders
- sulfanyl
- well
- signify
- Prior art date
Links
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 125000004414 alkyl thio group Chemical group 0.000 abstract 2
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 208000035475 disorder Diseases 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 abstract 1
- SVUOLADPCWQTTE-UHFFFAOYSA-N 1h-1,2-benzodiazepine Chemical compound N1N=CC=CC2=CC=CC=C12 SVUOLADPCWQTTE-UHFFFAOYSA-N 0.000 abstract 1
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 208000019695 Migraine disease Diseases 0.000 abstract 1
- 208000027418 Wounds and injury Diseases 0.000 abstract 1
- 238000007792 addition Methods 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 208000022531 anorexia Diseases 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 229940049706 benzodiazepine Drugs 0.000 abstract 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 abstract 1
- 210000001185 bone marrow Anatomy 0.000 abstract 1
- 210000003169 central nervous system Anatomy 0.000 abstract 1
- 210000004720 cerebrum Anatomy 0.000 abstract 1
- 229960003920 cocaine Drugs 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000006378 damage Effects 0.000 abstract 1
- 206010061428 decreased appetite Diseases 0.000 abstract 1
- 230000006806 disease prevention Effects 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 208000014674 injury Diseases 0.000 abstract 1
- 238000002483 medication Methods 0.000 abstract 1
- 206010027599 migraine Diseases 0.000 abstract 1
- 229960002715 nicotine Drugs 0.000 abstract 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 201000000980 schizophrenia Diseases 0.000 abstract 1
- 208000019116 sleep disease Diseases 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La invención se refiere al empleo de compuestos de fórmula general I (gráfico), en donde R1-R4 significan hidrógeno, halógeno, alquilo inferior alcoxilo inferior, arilo, benciloxilo, alcoxilo inferior-alquilo inferior, alquilo inferior-sulfanilo, alquilo inferior-sulfanilo-alquilo inferior, ó R1 y R2 juntos significan el grupo -O-(CH2)2 - ó - (CH2)2-O-, y R5 significa hidrógeno o hidroxilo así como también sus sales farmacéuticamente aceptables, en el control o prevención de enfermedades o trastornos del sistema nervioso central, tales como la migraña, esquizofrenia, estados de ansiedad, trastornos del sueño, anorexia, enfermedad de Alzheimer, adiciones (alcohol, nicotina, benzodiazepina, cocaína, etc.) así como también trastornos que resultan de lesiones en la cabeza/cerebroo en la columna vertebral/médula ósea, y respectivamente, para la elaboración de los correspondientes medicamentos.The invention relates to the use of compounds of general formula I (graph), wherein R1-R4 signify hydrogen, halogen, lower alkyl lower alkoxy, aryl, benzyloxy, lower alkoxy-lower alkyl, lower alkyl-sulfanyl, lower alkyl-sulfanyl -lower alkyl, or R1 and R2 together signify the group -O- (CH2) 2 - or - (CH2) 2-O-, and R5 signifies hydrogen or hydroxyl as well as their pharmaceutically acceptable salts, in the control or prevention of diseases or disorders of the central nervous system, such as migraine, schizophrenia, anxiety states, sleep disorders, anorexia, Alzheimer's disease, additions (alcohol, nicotine, benzodiazepine, cocaine, etc.) as well as disorders resulting from injury in the head / cerebrum or in the spinal column / bone marrow, and respectively, for the preparation of the corresponding medications.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP972101 ECSP972101A (en) | 1997-04-30 | 1997-04-30 | DERIVATIVES OF BENZOFURILE AND ITS USE |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP972101 ECSP972101A (en) | 1997-04-30 | 1997-04-30 | DERIVATIVES OF BENZOFURILE AND ITS USE |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP972101A true ECSP972101A (en) | 1998-04-24 |
Family
ID=42042932
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP972101 ECSP972101A (en) | 1997-04-30 | 1997-04-30 | DERIVATIVES OF BENZOFURILE AND ITS USE |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP972101A (en) |
-
1997
- 1997-04-30 EC ECSP972101 patent/ECSP972101A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO4940471A1 (en) | DERIVED FROM BENZOFURILE AND ITS USE | |
| DE69724108T2 (en) | ISOCHINOL DERIVATIVES AND MEDICINAL PRODUCTS | |
| CO4900068A1 (en) | PIPERAZINE DI - N - SUBSTITUTED AND PIPERIDINES 1,4-DI- SUBSTITUTED USEFUL AS MUSCARINIC ANTAGONISTS | |
| AR009937A1 (en) | PIRIMIDO [5,4-D] PIRIMIDINAS, MEDICINES CONTAINING THESE COMPOUNDS, THEIR USE AND PROCEDURE FOR THE PREPARATION | |
| PT641328E (en) | AZA-BICYCLIC DERIVATIVES IN BRIDGE AS ANTAGONISTS OF SUBSTANCE P | |
| PT1007043E (en) | METHOD FOR THE TREATMENT OF LYSOSOMIC STORAGE DISEASES WITH INVOLVEMENT OF CNS | |
| DE69807587D1 (en) | Quinazolin-4-one AMPA antagonists | |
| MX9300786A (en) | HYPOLIPIDAEMIC COMPOUNDS. | |
| AR007118A1 (en) | 4 (3H) -QUINAZOLINONES 2,3 DISSTITUTED AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM | |
| UY27078A1 (en) | DERIVATIVES OF QUINAZOLINE, DRUGS CONTAINING THESE COMPOUNDS, THEIR EMPLOYMENT AND PROCEDURES FOR THEIR PREPARATION | |
| CO4810373A1 (en) | ARYL-CONDENSED AZAPOLYCLIC COMPOUNDS | |
| UY24375A1 (en) | PROCEDURE FOR THE PREPARATION OF QUINOLIN-4-CARBOXAMIDE DERIVATIVES | |
| PE20020221A1 (en) | AZABYCYCLIC CARBAMATES AS AGONISTS OF THE ACETYLCHOLINE NICOTINUM alpha 7 RECEPTOR | |
| ECSP034646A (en) | DERIVATIVES OF QUINAZOLINE, DRUGS CONTAINING THESE COMPOUNDS, THEIR EMPLOYMENT AND PROCEDURES FOR THEIR PREPARATION | |
| DE69217945D1 (en) | AZANORBORN OTHER DERIVATIVES | |
| WO1999037623A3 (en) | Sulphonamide derivatives for treatment of cns disorders | |
| AR029454A1 (en) | PIPERAZINE DERIVATIVES REPLACED, PROCEDURES FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE IN THE DEVELOPMENT OF MEDICINES | |
| MX9704745A (en) | DERIVATIVES OF PIPERAZINE, MEDICINES CONTAINING THESE COMPOUNDS, THEIR USE AND PROCEDURES FOR THEIR PREPARATION. | |
| IT1219667B (en) | USE OF URIDINE IN THE PHARMACOLOGICAL TREATMENT OF DISORDERS DUE TO ALTERATED DOPAMINERGIC BALANCE | |
| UY26513A1 (en) | NEW REPLACED PIPERIDINES, MEDICINES CONTAINING THESE COMPOUNDS AND PROCEDURE FOR THEIR PREPARATION. | |
| DE69116378D1 (en) | SUBSTITUTED PIPERAZINE AS A MEDIUM FOR TREATING THE CENTRAL NERVOUS SYSTEM | |
| KR100397721B1 (en) | Benzopyran and Their Use as Therapeutic Agents | |
| ATE57922T1 (en) | OPTIONALLY SUBSTITUTED 1-(2'-(BIS-(PHENYL)-METHOXY>-AETHYL)-4-(3'-(BISPHENYL)-METHOXY>-PROPYL)-PIPERAZINE, PROCESS FOR THEIR PREPARATION AND MEDICINAL PRODUCTS CONTAINING THEM. | |
| PA8471301A1 (en) | ARYL-CONDENSED AZAPOLYCLIC COMPOUNDS | |
| ECSP972101A (en) | DERIVATIVES OF BENZOFURILE AND ITS USE |